The local ecosystem thrives because experts from institutions like Harvard, Biogen, and MGH continually join forces to create new ventures, leveraging a shared pool of specialized knowledge and experience from established players.

While Polaroid was foundational to Kendall Square's rise, its eventual decline after losing its innovative edge serves as a stark warning. This historical parallel highlights the risk of complacency for the current biotech sector, emphasizing that market leadership is fleeting and can be lost to competition.

Former industrial cities are experiencing a renaissance as potential biotech hubs. They offer a unique combination of established universities, a history of manufacturing, and, crucially, low property and living costs left over from de-industrialization, creating an attractive environment for startups.

Contrary to viewing regulation as only a barrier, the Cambridge City Council's decision to formally allow recombinant DNA research created a stable, sanctioned environment. This government approval was crucial for attracting investment and university talent to a controversial technology, turning it into a foundational industry.

Cities vying for biotech hub status can experience rapid real estate development that outpaces demand during industry downturns. This leads to high vacancy rates and cheaper lab space, a boon for small biotechs but a risk for developers and a warning for other aspiring cities.

Responding to Wall Street pressure to de-risk, large pharmaceutical firms cut internal early-stage research. This led to an exodus of talent and the rise of contract research organizations (CROs), creating an infrastructure that, like cloud computing for tech, lowered the barrier for new biotech startups.

Thriving life sciences ecosystems in Ireland, the UK, and Massachusetts did not grow by accident. Their success is the result of deliberate, long-term government strategies, including tax incentives, shared R&D infrastructure like the UK's 'Catapult' network, and fostering deep connections between technology, hospitals, and capital.

Instead of creating a tech sector from scratch, the most effective path is to identify and invest in tech niches adjacent to a city's existing industries (e.g., Energy Tech for an oil town). This leverages existing talent, infrastructure, and supply chains, making the transition more natural and sustainable.

Boston's historical strength lies in its co-located universities, capital, and talent. To maintain dominance, its new competitive advantage must be the interconnectivity of these components. The ecosystem that builds the fastest learning and iteration cycles will win, not just the one with the best raw ingredients.